{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:17Z","timestamp":1790484317618,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00223-006-0060-0","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T09:50:10Z","timestamp":1156499410000},"page":"69-75","source":"Crossref","is-referenced-by-count":32,"title":["Methotrexate, Azathioprine, Cyclosporine, and Risk of Fracture"],"prefix":"10.1007","volume":"79","author":[{"given":"P.","family":"Vestergaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mosekilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"60_CR1","first-page":"702","volume-title":"Basic and Clinical Pharmacology","author":"SE Salmon","year":"1987","unstructured":"Salmon SE (1987) Drugs and the immune system. In: Katzung BG (ed), Basic and Clinical Pharmacology. Appleton & Lange, East Norwalk, CT, pp 702\u2013718"},{"key":"60_CR2","first-page":"S58","volume":"18","author":"GF Ferraccioli","year":"2000","unstructured":"Ferraccioli GF, Di Poi E, Damato R (2000) Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives. Clin Exp Rheumatol 18:S58\u2013S60","journal-title":"Clin Exp Rheumatol"},{"key":"60_CR3","first-page":"624","volume":"23","author":"G Ferraccioli","year":"1996","unstructured":"Ferraccioli G, Salaffi F, De Vita S, et al. (1996) Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. J Rheumatol 23:624\u2013628","journal-title":"J Rheumatol"},{"key":"60_CR4","unstructured":"Davies H, Olson L, Gibson P (2000) Methotrexate as a steroid sparing agent for asthma in adults. Cochrane Database Syst Rev CD000391"},{"key":"60_CR5","first-page":"87","volume":"16","author":"SJ Lewis","year":"1999","unstructured":"Lewis SJ, Ainslie GM, Bateman ED (1999) Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:87\u201392","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","volume":"257","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257:374\u2013384","journal-title":"J Intern Med"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa van","year":"2000","unstructured":"van Staa TP, Leufkens HGM, Abenhaim L, et al. (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","volume":"16","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Leufkens HGM, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581\u2013588","journal-title":"J Bone Miner Res"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","volume":"48","author":"TP Staa van","year":"2003","unstructured":"van Staa TP, Laan RF, Barton IP, et al. (2003) Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 48:3224\u20133229","journal-title":"Arthritis Rheum"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/8756-3282(94)90309-3","volume":"15","author":"J Herrala","year":"1994","unstructured":"Herrala J, Puolijoki H, Impivaara O, et al. (1994) Bone mineral density in asthmatic women on high dose inhaled beclomethasone dipropionate. Bone 15:621\u2013623","journal-title":"Bone"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-119-10-199311150-00001","volume":"119","author":"RF Laan","year":"1993","unstructured":"Laan RF, van Riel PL, van de Putte LB, et al. (1993) Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomised controlled study. Ann Intern Med 119:963\u2013968","journal-title":"Ann Intern Med"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","volume":"355","author":"CA Wong","year":"2000","unstructured":"Wong CA, Walsh LJ, Smith CJ, et al. (2000) Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet 355:1399\u20131403","journal-title":"Lancet"},{"key":"60_CR13","first-page":"495","volume":"19","author":"RF Spiera","year":"2001","unstructured":"Spiera RF, Mitnick HJ, Kupersmith M, et al. (2001) A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19:495\u2013501","journal-title":"Clin Exp Rheumatol"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00198-004-1606-5","volume":"15","author":"TP Staa van","year":"2004","unstructured":"van Staa TP, Bishop N, Leufkens HG, et al. (2004) Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporosis Int 15:785\u2013791","journal-title":"Osteoporosis Int"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1200\/JCO.2000.18.7.1570","volume":"18","author":"J Pfeilschifter","year":"2000","unstructured":"Pfeilschifter J, Diel IJ (2000) Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol 18:1570\u20131593","journal-title":"J Clin Oncol"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1096-911X(20001001)35:4<415::AID-MPO4>3.0.CO;2-9","volume":"35","author":"I Sluis van der","year":"2000","unstructured":"van der Sluis I, van den Heuvel-Eibrink MM, Hahlen K, et al. (2000) Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 35:415\u2013420","journal-title":"Med Pediatr Oncol"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2106\/00004623-198466040-00016","volume":"66","author":"GE Friedlaender","year":"1984","unstructured":"Friedlaender GE, Tross RB, Doganis AC, et al. (1984) Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (Adriamycin) treatment in a rat model. J Bone Joint Surg Am 66:602\u2013607","journal-title":"J Bone Joint Surg Am"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jor.1100030111","volume":"3","author":"RR Pelker","year":"1985","unstructured":"Pelker RR, Friedlaender GE, Panjabi MM, et al. (1985) Chemotherapy-induced alterations in the biomechanics of rat bone. J Orthop Res 3:91\u201395","journal-title":"J Orthop Res"},{"key":"60_CR19","first-page":"227","volume":"14","author":"S Gnudi","year":"1988","unstructured":"Gnudi S, Butturini L, Ripamonti C, et al. (1988) The effects of methotrexate (MTX) on bone. A densitometric study conducted on 59 patients with MTX administered at different doses. Ital J Orthop Traumatol 14:227\u2013231","journal-title":"Ital J Orthop Traumatol"},{"key":"60_CR20","first-page":"1489","volume":"24","author":"LM Buckley","year":"1997","unstructured":"Buckley LM, Leib ES, Cartularo KS, et al. (1997) Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol 24:1489\u20131494","journal-title":"J Rheumatol"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002239900585","volume":"64","author":"LD Carbone","year":"1999","unstructured":"Carbone LD, Kaeley G, McKown KM, et al. (1999) Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64:100\u2013101","journal-title":"Calcif Tissue Int"},{"key":"60_CR22","first-page":"2395","volume":"28","author":"AB Cranney","year":"2001","unstructured":"Cranney AB, McKendry RJ, Wells GA, et al. (2001) The effect of low dose methotrexate on bone density. J Rheumatol 28:2395\u20132399","journal-title":"J Rheumatol"},{"key":"60_CR23","first-page":"1305","volume":"31","author":"O Di Munno","year":"2004","unstructured":"Di Munno O, Mazzantini M, Sinigaglia L, et al. (2004) Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 31:1305\u20131309","journal-title":"J Rheumatol"},{"key":"60_CR24","first-page":"327","volume":"18","author":"M Mazzantini","year":"2000","unstructured":"Mazzantini M, Di Munno O, Incerti-Vecchi L, et al. (2000) Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate. Clin Exp Rheumatol 18:327\u2013331","journal-title":"Clin Exp Rheumatol"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/rheumatology\/41.7.741","volume":"41","author":"NJ Minaur","year":"2002","unstructured":"Minaur NJ, Kounali D, Vedi S, et al. (2002) Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatology (Oxford) 41:741\u2013749","journal-title":"Rheumatology (Oxford)"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00296-003-0298-z","volume":"23","author":"F Tascioglu","year":"2003","unstructured":"Tascioglu F, Oner C, Armagan O (2003) The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int 23:231\u2013235","journal-title":"Rheumatol Int"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/1097-0142(197003)25:3<580::AID-CNCR2820250313>3.0.CO;2-M","volume":"25","author":"AH Ragab","year":"1970","unstructured":"Ragab AH, Frech RS, Vietti TJ (1970) Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 25:580\u2013585","journal-title":"Cancer"},{"key":"60_CR28","first-page":"139","volume":"125","author":"S Stanisavljevic","year":"1977","unstructured":"Stanisavljevic S, Babcock AL (1977) Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res 125:139\u2013144","journal-title":"Clin Orthop Relat Res"},{"key":"60_CR29","first-page":"77","volume":"20","author":"HM Maenpaa","year":"2002","unstructured":"Maenpaa HM, Soini I, Lehto MU, et al. (2002) Insufficiency fractures in patients with chronic inflammatory joint diseases. Clin Exp Rheumatol 20:77\u201379","journal-title":"Clin Exp Rheumatol"},{"key":"60_CR30","first-page":"1539","volume":"23","author":"G Ferraccioli","year":"1996","unstructured":"Ferraccioli G, Casatta L, Bartoli E (1996) Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy. J Rheumatol 23:1539\u20131542","journal-title":"J Rheumatol"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1378\/chest.109.5.1176","volume":"109","author":"RM Aris","year":"1996","unstructured":"Aris RM, Neuringer IP, Weiner MA, et al. (1996) Severe osteoporosis before and after lung transplantation. Chest 109:1176\u20131183","journal-title":"Chest"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","volume":"135","author":"S Wacholder","year":"1992","unstructured":"Wacholder S, McLaughlin JK, Silverman DT, et al. (1992) Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135:1019\u20131028","journal-title":"Am J Epidemiol"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eat.10101","volume":"32","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Emborg C, St\u00f8ving RK, et al. (2002) Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders - a nation-wide register study. Int J Eat Disord 32:301\u2013308","journal-title":"Int J Eat Disord"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.0013-9580.2004.18804.x","volume":"45","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2004) Fracture risk associated with use of anti-epileptic drugs. Epilepsia 45:1330\u20131337","journal-title":"Epilepsia"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00223-004-0084-2","volume":"76","author":"L Rejnmark","year":"2005","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2005) Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 76:167\u2013175","journal-title":"Calcif Tissue Int"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","volume":"259","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Fracture risk in patients treated with loop diuretics. J Intern Med 259:117\u2013124","journal-title":"J Intern Med"},{"key":"60_CR37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2000","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB, et al. (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739","journal-title":"J Bone Miner Res"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johansson H, Johnell O, et al. (2005) Alcohol intake as a risk factor for fracture. Osteoporosis Int 16:737\u2013742","journal-title":"Osteoporosis Int"},{"key":"60_CR39","first-page":"263","volume":"46","author":"TF Andersen","year":"1999","unstructured":"Andersen TF, Madsen M, J\u00f8rgensen J, et al. (1999) The Danish National Hospital Register. Dan Med Bull 46:263\u2013268","journal-title":"Dan Med Bull"},{"key":"60_CR40","first-page":"82","volume":"44","author":"P Munk-J\u00f8rgensen","year":"1997","unstructured":"Munk-J\u00f8rgensen P, Mortensen PB (1997) The Danish Psychiatric Central Register. Dan Med Bull 44:82\u201384","journal-title":"Dan Med Bull"},{"key":"60_CR41","first-page":"3741","volume":"157","author":"J Mosbech","year":"1995","unstructured":"Mosbech J, J\u00f8rgensen J, Madsen M, et al. (1995) The Danish National Patient Register: evaluation of data quality [in Danish]. Ugeskr L\u00e6ger 157:3741\u20133745","journal-title":"Ugeskr L\u00e6ger"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwf007","volume":"156","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn\u2019s disease, and ulcerative colitis: a nation-wide follow-up study in 16,416 patients in Denmark. Am J Epidemiol 156:1\u201310","journal-title":"Am J Epidemiol"},{"key":"60_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archderm.1996.03890260086013","volume":"132","author":"IM Zonneveld","year":"1996","unstructured":"Zonneveld IM, Bakker WK, Dijkstra PF, et al. (1996) Methotrexate osteopathy in long-term, low-dose methotrexate treatment for psoriasis and rheumatoid arthritis. Arch Dermatol 132:184\u2013187","journal-title":"Arch Dermatol"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/ctrv.2000.0180","volume":"26","author":"BL Leeuwen Van","year":"2000","unstructured":"Van Leeuwen BL, Kamps WA, Jansen HW, et al. (2000) The effect of chemotherapy on the growing skeleton. Cancer Treat Rev 26:363\u2013376","journal-title":"Cancer Treat Rev"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.blo.0000073348.50837.f2","volume":"413","author":"BL Leeuwen Van","year":"2003","unstructured":"Van Leeuwen BL, Verkerke GJ, Hartel RM, et al. (2003) Chemotherapy decreases epiphyseal strength and increases bone fracture risk. Clin Orthop Relat Res 413:243\u2013254","journal-title":"Clin Orthop Relat Res"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/oxfordjournals.aje.a009760","volume":"149","author":"S Hoidrup","year":"1999","unstructured":"Hoidrup S, Gr\u00f8nb\u00e6k M, Gottschau A, et al. (1999) Alcohol intake, beverage preference, and risk of hip fracture in men and women. Am J Epidemiol 149:993\u20131001","journal-title":"Am J Epidemiol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-006-0060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-006-0060-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:37:50Z","timestamp":1558683470000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-006-0060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s00223-006-0060-0","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}